This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: None, Subject name: Ophthalmology
[{'content': 'Which of the following drug is used curvently for the prophylaxis of non infectious uveitis in LUMINATE programme \nSelect and explain. \nA. Cyclosporine, B. Voclosporine, C. Methotrexate, D. lnfli xi mib', 'role': 'user'}, {'content': 'Answer: B \nExplanation: B i.e. Voclosporine - LUMINATE (i.e. Lux Uveitis Multicentre Investigations of a New Approch Treatment) programme is a scientific drug trial (staed in 2007 and completed in 2009) for uveitis. In this programme a pivotal study LUVENIQ (LX-211) assessed the safety and efficacy of oral form of next generation calcineurin inhibitor, Voclosporin for treatment of sight threatening non infectious uveitis (as a steroid sparing therapy). - LX - 212 Programme : In this a bioerodible polymer implant containing voclosporin is implanted, using minimally invasive approach; which release active ingradient slowly & steadily to the surface of eye. - LX - 214 Programme : In this topical formulation (eye drop) of nanomicelles of voclosporin (which in not normally soluble in aqueous media) is used for dry eye, atopic kerato conjunctivitis & blepharitis. LUMITECT Programme and LUCIDA/ LX-201 (i.e. Lux Corneal Transplant Implant Development & Advancement of Therapy) Study : In this silicon matrix ocular (episcleral)implant that steadily releases therapeutic dose of cyclosporine A is used for prevention of rejection of corneal transplant.', 'role': 'assistant'}]